Hideki Goto

12PUBLICATIONS
58CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 24, 2026
Real-World Safety and Efficacy of Pola-R-CHP in Previously Untreated DLBCL: POLASTAR Interim Analysis of 500 Patients.

|Apr 22, 2026
Drivers of temporal improvement in CAR T-cell therapy for large B-cell lymphoma: a Japanese nationwide registry analysis.

|Oct 02, 2025
Mosunetuzumab Plus Polatuzumab Vedotin in Transplant-Ineligible Refractory/Relapsed Large B-Cell Lymphoma: Primary Results of the Phase III SUNMO Trial.

Lihua E Budde, Huilai Zhang, Won-Seog Kim

|Sep 02, 2025
Long-term outcomes of venetoclax and ibrutinib in Japanese patients with relapsed/refractory mantle cell lymphoma.

Hideki Goto, Satoshi Ito, Masahiro Kizaki

|Dec 09, 2024
Efficacy and safety of mosunetuzumab monotherapy for Japanese patients with relapsed/refractory follicular lymphoma: FLMOON-1.

Hideki Goto, Takahiro Kumode, Yuko Mishima

|May 25, 2024
Novel CAR T cell therapies for patients with large B cell lymphoma.

Hideki Goto, Masahiro Onozawa, Takanori Teshima

Pageof 2

Frequent Collaborators

2 joint publications

Toshihiro Matsukawa

2 joint publications

Takanori Teshima

1 joint publications

Toru Miyajima

1 joint publications

Masahiro Onozawa